- Home
- IQV vs FMX Comparison
IQV vs FMX Comparison
Compare IQV & FMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IQV | FMX |
|---|---|---|
| Founded | 1982 | 1890 |
| Country | United States | Mexico |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.3B | 38.1B |
| IPO Year | 2013 | 1998 |
Fundamental Metrics
Financial Performance| Metric | IQV | FMX |
|---|---|---|
| Price | $164.74 | $106.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 7 |
| Target Price | ★ $230.56 | $108.83 |
| AVG Volume (30 Days) | ★ 2.4M | 342.9K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.60% |
| EPS Growth | ★ 4.67 | N/A |
| EPS | ★ 7.84 | N/A |
| Revenue | ★ $9,739,000,000.00 | N/A |
| Revenue This Year | $6.76 | $10.25 |
| Revenue Next Year | $5.85 | $8.35 |
| P/E Ratio | ★ $20.74 | $40.94 |
| Revenue Growth | ★ 41.60 | N/A |
| 52 Week Low | $134.65 | $83.08 |
| 52 Week High | $247.05 | $116.09 |
Technical Indicators
Market Signals| Indicator | IQV | FMX |
|---|---|---|
| Relative Strength Index (RSI) | 36.48 | 41.25 |
| Support Level | $156.43 | $104.99 |
| Resistance Level | $166.38 | $106.86 |
| Average True Range (ATR) | 6.33 | 2.72 |
| MACD | 1.34 | -0.82 |
| Stochastic Oscillator | 20.98 | 1.95 |
Price Performance
Historical ComparisonAbout IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About FMX Fomento Economico Mexicano S.A.B. de C.V.
Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up 75% of total company revenue and over 90% of profits in 2024.